Ong E W, Xue L, Olmstead M C, Cahill C M
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada; Department of Anaesthesiology and Perioperative Care, University of California, Irvine, CA, USA.
Br J Pharmacol. 2015 Jan;172(2):615-29. doi: 10.1111/bph.12761. Epub 2014 Jul 1.
The δ opioid receptor (DOP receptor) undergoes internalization both constitutively and in response to agonists. Previous work has shown that DOP receptors traffic from intracellular compartments to neuronal cell membranes following prolonged morphine treatment. Here, we examined the effects of prolonged morphine treatment on the post-internalization trafficking of DOP receptors.
Using primary cultures of dorsal root ganglia neurons, we measured the co-localization of endogenous DOP receptors with post-endocytic compartments following both prolonged and acute agonist treatments.
A departure from the constitutive trafficking pathway was observed following acute DOP receptor agonist-induced internalization by deltorphin II. That is, the DOP receptor underwent distinct agonist-induced post-endocytic sorting. Following prolonged morphine treatment, constitutive DOP receptor trafficking was augmented. SNC80 following prolonged morphine treatment also caused non-constitutive DOP receptor agonist-induced post-endocytic sorting. The μ opioid receptor (MOP receptor) agonist DAMGO induced DOP receptor internalization and trafficking following prolonged morphine treatment. Finally, all of the alterations to DOP receptor trafficking induced by both DOP and MOP receptor agonists were inhibited or absent when those agonists were co-administered with a DOP receptor antagonist, SDM-25N.
The results support the hypothesis that prolonged morphine treatment induces the formation of MOP-DOP receptor interactions and subsequent augmentation of the available cell surface DOP receptors, at least some of which are in the form of a MOP/DOP receptor species. The pharmacology and trafficking of this species appear to be unique compared to those of its individual constituents.
This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
δ阿片受体(DOP受体)可组成性内化,也可对激动剂产生反应而内化。先前的研究表明,长期吗啡治疗后,DOP受体从细胞内区室转运至神经元细胞膜。在此,我们研究了长期吗啡治疗对DOP受体内化后转运的影响。
利用背根神经节神经元的原代培养物,我们测量了长期和急性激动剂处理后内源性DOP受体与内吞后区室的共定位。
在急性DOP受体激动剂二丙诺啡诱导的内化后,观察到其偏离了组成性转运途径。也就是说,DOP受体经历了独特的激动剂诱导的内吞后分选。长期吗啡治疗后,组成性DOP受体转运增强。长期吗啡治疗后的SNC80也导致非组成性DOP受体激动剂诱导的内吞后分选。μ阿片受体(MOP受体)激动剂DAMGO在长期吗啡治疗后诱导DOP受体内化和转运。最后,当这些激动剂与DOP受体拮抗剂SDM - 25N共同给药时,由DOP和MOP受体激动剂诱导的DOP受体转运的所有改变均受到抑制或不存在。
结果支持以下假设,即长期吗啡治疗诱导MOP - DOP受体相互作用的形成以及随后可用细胞表面DOP受体的增加,其中至少一些是以MOP / DOP受体复合物的形式存在。与单个成分相比,该复合物的药理学和转运似乎是独特的。
本文是关于阿片类药物:功能选择性新途径的主题部分的一部分。要查看本部分的其他文章,请访问http://dx.doi.org/10.1111/bph.2015.172.issue - 2。